Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed Evidence into Clinical Workflows

On April 15, 2026, Abridge announced multi-year content partnerships with NEJM Group, publisher of the New England Journal of Medicine, and the American Medical Association, publisher of the JAMA Network, to integrate peer-reviewed medical evidence directly into its AI-powered clinical conversation platform. This collaboration aims to enhance clinical decision support by bringing trusted research from two of the most influential medical journals into the flow of patient care.

The partnerships enable clinicians using Abridge to access evidence-based insights from the New England Journal of Medicine, JAMA, and the broader JAMA Network family of publications before, during, and after patient conversations. These insights are surfaced within Abridge’s platform as part of its clinical decision support capabilities, where clinicians can request clinical questions and receive information grounded in both peer-reviewed research and the specific context of the patient encounter.

Abridge’s platform supports the full arc of a clinical encounter, including helping clinicians prepare for visits, capturing and structuring patient conversations, generating documentation, and delivering cited, evidence-based responses to clinical inquiries—all within a single workflow. By embedding journal content into this process, the company seeks to reduce the cognitive burden on clinicians who must stay current with rapidly evolving medical knowledge while maintaining focus on patient interaction.

According to Dr. Shiv Rao, CEO and co-founder of Abridge and a practicing cardiologist, the integration addresses a critical challenge in modern medicine: “Clinicians are managing more complexity than ever. These content partnerships will make trusted clinical evidence available without breaking their focus on the patient.” He emphasized that the New England Journal of Medicine and JAMA represent the highest scientific standards in medicine, and ensuring their research is accessible at the point of care is central to Abridge’s mission.

The collaboration reflects a broader trend in health technology toward embedding authoritative, evidence-based resources directly into clinical workflows to improve decision-making and reduce delays in care. By linking peer-reviewed literature to real-time patient conversations, Abridge aims to create a more seamless experience where clinical guidance is not only accurate but as well contextually relevant to the individual being treated.

As of the announcement date, the partnerships are active and form part of Abridge’s ongoing expansion of its clinical decision support infrastructure. The financial and operational terms of the agreements were not disclosed in the public announcements.